Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc.

NASDAQ:CODX

Overview | Financials
Company Name Co-Diagnostics, Inc.
Symbol CODX
Currency USD
Price 1.27
Market Cap 39,723,568
Dividend Yield 0%
52-week-range 0.981 - 1.89
Industry Medical Devices
Sector Healthcare
CEO Mr. Dwight H. Egan
Website https://www.codiagnostics.com

An error occurred while fetching data.

About Co-Diagnostics, Inc.

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus,

Related Stocks

Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc.

MIST

1.55 USD

Omeros Corporation logo

Omeros Corporation

OMER

4.88 USD

CymaBay Therapeutics, Inc. logo

CymaBay Therapeutics, Inc.

CBAY

32.48 USD

Mainz Biomed B.V. logo

Mainz Biomed B.V.

MYNZ

0.38 USD

Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc.

ALDX

3.87 USD

Inozyme Pharma, Inc. logo

Inozyme Pharma, Inc.

INZY

5.32 USD

Rhythm Pharmaceuticals, Inc. logo

Rhythm Pharmaceuticals, Inc.

RYTM

49.26 USD

OptiNose, Inc. logo

OptiNose, Inc.

OPTN

1.08 USD

Financials

Numbers are in millions USD

Numbers are in millions USD